Search Our Site

Advanced Medical Strategies provides predictive clinical and financial analytic tools, allowing payers deep insight into catastrophic healthcare claims.

Evaluate and predict costs & clinical treatments for high dollar diagnoses by state with in-depth information on pending investigational therapies, pipeline drugs, and up to date physician commentary on standards of care treatment protocols


A comprehensive solution for specialty drugs that evaluates cost data, FDA approved indications, notable off-label usage, adult and pediatric dosing regimens, specialty drug coding, and critical physician commentary


The only online, fully transparent implant cost directory in the industry. ImplantDx offers clients the references they need for implant cost containment with on demand analytics

The Predict Suite – Something for Everyone

Understanding & Predicting Risk

Increased Productivity

Loss Ratio Management

Invoice Validation

The Predict Suite provides industry-leading modular clinical and financial cost and predictive analytical solutions through a web-based platform and supplementary professional services. This platform allows payers to address the challenges associated with managing, reimbursing, and underwriting catastrophic medical claims. With just a login and password executives, claims managers, sales professionals and underwriting teams can gain valuable insight into the critical information needed to be effective in today’s healthcare environment.



reduction in claims cost



increase in quality assurance



saved on average


For Every Service We Perform, Your Success is Our Priority

As a physician-led organization, Advanced Medical Strategies brings forth some of the most innovative & proactive solutions in the Health Care and Workers' Compensation Payor industry today. In addition to saving our clients time and money, we provide peace of mind when dealing with all complicated pieces that can happen when reimbursing claims.

What We Achieve

♦ A clinical and financial view of claims to produce the best possible outcome

♦ Claims savings via fair and defensible claim reviews

♦ Peace of mind with unbiased clinical reviews in complex cases

♦ Simplification of complex cases through complimentary screening process

♦ Maintaining collaborative relationships by recognizing payor politics

  • In September 2016, the US Food and Drug Administration (FDA) approved eteplirsen (Exondys 51), a new drug for Duchenne muscular dystrophy (DMD), overruling the recommendations of both its scientific staff and its external advisory committee. Duchenne muscular dystrophy is a progressive and usually fatal X-linked genetic disease caused by mutations in a gene that produces... Read More »
  • A line in an article I was reading the other day gave me pause: “The age-adjusted mortality rate for cancer is essentially unchanged over the past half-century, at about 200 deaths per 100,000 people.” Could this be true? If so, it made me wonder if—with all our state-of-the-art technologies, advanced medicines, and decades’ worth of... Read More »



dollars Saved

We have saved tens of millions of dollars for our clients and subscribers


Subscribers Retained

We have retained 100% of our subscribers


Sub Specialty Physicians

700+ specialty physicians in our peer review panel


Weekly Hours Saved

We have saved our clients and subscribers 100's of weekly hours in research, analysis, and underwriting